У нас вы можете посмотреть бесплатно UHMS 12 Refractory Osteomyelitis или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
#RefractoryOsteomyelitis #BoneInfection #HyperbaricOxygenTherapy #HBOT #AdjunctiveTherapy #SurgicalDebridement #Antibiotics #Triad #DiabeticFootUlcer #SpinalOsteomyelitis #SternalOsteomyelitis #CranialOsteomyelitis #AHARecommendations #CostEffective Refractory osteomyelitis is a bone infection that fails to resolve after 30+ days of standard surgery and antibiotics. Hyperbaric Oxygen Therapy (HBO2) is a safe, adjunctive treatment. It works by increasing oxygen in infected tissue, enhancing immune function, boosting antibiotic effectiveness, and promoting healing. Best results are seen with the synergistic triad: culture-directed antibiotics, surgical debridement, and HBO2. Evidence, though primarily lower-level human studies, supports HBO2 use in refractory cases, often achieving 80-90% cure rates when part of the triad. It is a Class 1 recommendation for severe diabetic foot osteomyelitis (Wagner 3/4), significantly reducing amputation risk. It's Class 2a for critical sites (spine, cranium, sternum, pediatric) and severe cases with the triad, potentially avoiding extensive surgery. Treatment typically involves daily sessions (90-120 min, 2.4-2.5 ATA) for 4-6 weeks (20-40 sessions). If improvement is poor after 30-40 sessions, reassess and modify surgery/antibiotics before reinstituting HBO2. Continuing a failing regimen is Class 3. Safety is good, with rare minor barotrauma or transient vision changes reported. HBO2 can reduce overall healthcare costs by preventing repeat procedures and lengthy hospital stays.